Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2015-12-08Clinical Trial Update: Clarithromycin, Sulfamethoxazole/Trimethoprim or Observation in Newly Diagnosed Multiple Myeloma [Phase 2]
Phase 2 trial evaluating clarithromycin or sulfamethoxazole/trimethoprim versus observation in newly diagnosed multiple myeloma to address i…
-
CLINICAL_TRIALS trial_result · 2015-12-07Clinical Trial Update: A Study of Tanespimycin (KOS-953) in Patients With Relapsed-refractory Multiple Myeloma [Phase 2, Phase 3]
Clinical Trial Update reporting on a Phase 2/Phase 3 study of Tanespimycin (KOS-953) in relapsed-refractory multiple myeloma, with the trial…
-
CLINICAL_TRIALS trial_result · 2015-12-04Clinical Trial Update: Temsirolimus and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma [Phase 1]
Phase 1 clinical trial evaluating temsirolimus in combination with dexamethasone for recurrent or refractory multiple myeloma; the study has…
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma [Phase 2]
This is a Phase 2 clinical trial update for carfilzomib in relapsed multiple myeloma. The Phase 2 study is completed and results were posted…
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: Safety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological Malignancies [Phase 1]
Phase 1 safety study of carfilzomib (PR-171) in hematologic malignancies has completed and results were posted in 2015.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: A Study to Further Assess Safety and Effectiveness Data of the Bortezomib(Velcade)/Melphalan/Prednisone (BMP) Regimen in Previously Untreated and Transplant Ineligible Multiple Myeloma Patients
This entry updates a clinical trial evaluating the BMP regimen (bortezomib, melphalan, prednisone) for previously untreated, transplant-inel…
-
FDA approval · 2015-12-01FDA Approved: POMALYST — Supplemental Application (Celgene Corporation)
FDA approved a supplemental application for POMALYST (pomalidomide) from Celgene Corporation, resulting in updated labeling for the product.
-
FDA approval · 2015-11-30FDA Approved: EMPLICITI — Original Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved Empliciti (elotuzumab) under original BLA 761035 for the treatment of multiple myeloma in adults, in combination with lenal…
-
CLINICAL_TRIALS trial_result · 2015-11-30Clinical Trial Update: Clinical Ex Vivo Expansion of Human Umbilical Cord Blood Stem and Progenitor Cells [Phase 1, Phase 2]
An update on a Phase 1/2 trial evaluating ex vivo expansion of human umbilical cord blood stem and progenitor cells for patients with acute …
-
FDA approval · 2015-11-20FDA Approved: NINLARO — Original Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved NINLARO (ixazomib) in its original application from Takeda Pharmaceuticals America, Inc. for the treatment of multiple myel…
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Lenalidomide and Rituximab in Treating Patients With Recurrent and/or Refractory Multiple Myeloma [Phase 2]
Phase 2 trial evaluating lenalidomide plus rituximab in patients with recurrent or refractory multiple myeloma; the study was terminated wit…
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Geriatric Assessments in Senior Adults With Multiple Myeloma
This update summarizes a completed clinical trial evaluating geriatric assessments in older adults with multiple myeloma.
-
FDA approval · 2015-11-16FDA Approved: DARZALEX — Original Application (Janssen Biotech, Inc.)
FDA approved the original application for DARZALEX (daratumumab) from Janssen Biotech, Inc., establishing its use for treating multiple myel…
-
CLINICAL_TRIALS trial_result · 2015-11-13Clinical Trial Update: C11-Acetate PET/CT in Multiple Myeloma: Added Value to F18-Fluorodeoxyglucose PET/CT [NA]
This completed trial assesses the value of C11-acetate PET/CT in multiple myeloma and its added value over F18-FDG PET/CT.
-
CLINICAL_TRIALS trial_result · 2015-11-10Clinical Trial Update: Japanese Phase 2 Study to Evaluate the Efficacy and Safety of Pomalidomide in Subjects With Relapsed and Refractory Multiple Myeloma [Phase 2]
A Phase 2 Japanese study evaluating the efficacy and safety of pomalidomide in relapsed and refractory multiple myeloma has completed with r…
-
CLINICAL_TRIALS trial_result · 2015-11-10Clinical Trial Update: Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating donor umbilical cord blood transplant after fludarabine phosphate, cyclophosphamide, and total-body irradiation i…
-
CLINICAL_TRIALS trial_result · 2015-11-04Clinical Trial Update: IFM2009-02-Pomalidomide and Dexamethasone Phase 2 Myeloma [Phase 2]
Phase 2 trial evaluating pomalidomide in combination with dexamethasone for multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2015-11-04Clinical Trial Update: Study of Carfilzomib in Combination w/Dexamethasone in Patients w/Newly Diagnosed Multiple Myeloma [Phase 2]
This Phase 2 trial of carfilzomib plus dexamethasone in newly diagnosed multiple myeloma was terminated, and results have been posted.
-
CLINICAL_TRIALS withdrawal · 2015-10-26Clinical Trial Update: UARK 2006-28 Human Cord Blood Transplantation in Advanced Hematological Malignancies [Phase 1]
A phase 1 clinical trial (UARK 2006-28) of human cord blood transplantation in advanced hematological malignancies has been withdrawn.
-
CLINICAL_TRIALS research · 2015-10-26Clinical Trial Update: UARK 2009-32 Compassionate Use Study of Carfilzomib
Compassionate-use study of carfilzomib for multiple myeloma is no longer available (status NO_LONGER_AVAILABLE).
-
CLINICAL_TRIALS trial_result · 2015-10-23Clinical Trial Update: Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma [Phase 3]
Phase 3 trial evaluating panobinostat or placebo with bortezomib and dexamethasone in relapsed multiple myeloma has completed with results p…
-
CLINICAL_TRIALS trial_result · 2015-10-22Clinical Trial Update: Safety and Preliminary Efficacy Study of the Antibody PAT-SM6 in Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]
Phase 1 safety and preliminary efficacy study of PAT-SM6 in relapsed or refractory multiple myeloma; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-21Clinical Trial Update: UARK 2003-33, Total Therapy III [Phase 2]
Phase 2 trial update for Total Therapy III in multiple myeloma. Results have been posted.
-
FDA approval · 2015-10-19FDA Approved: ZOLEDRONIC ACID — Supplemental Application (BPI Labs LLC)
FDA approves a supplemental application for zoledronic acid from BPI Labs LLC under ANDA 202930. This action supports continued availability…
-
CLINICAL_TRIALS trial_result · 2015-10-14Clinical Trial Update: Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma [Phase 1]
Phase 1 clinical trial update of Interferon alfa in patients with stage IV solid tumors, lymphoma, or multiple myeloma; the study status is …